Cancer clinical trials in the region Normandie
102 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
Targeted therapy
Systemic Treatment-Naive
6 main criterias to confirm
Janssen
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
None
Systemic Treatment-Naive
7 main criterias to confirm
Janssen
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
EGFR
None
Chemotherapy
Radiotherapy
8 main criterias to confirm
AstraZeneca
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Localized
ALK
None
Systemic Treatment-Naive
Surgery
8 main criterias to confirm
Hoffmann-La Roche
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Localized
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
None
Systemic Treatment-Naive
ALK
EGFR
8 main criterias to confirm
Bristol-Myers Squibb
Early Access
Lung cancer
SCLC (Small Cell Lung Cancer)
Localized
Locally Advanced
None
Chemotherapy
Radiotherapy
Chemotherapy
Radiotherapy
7 main criterias to confirm
AstraZeneca
Phase 3
Kidney cancer
#NCT06364631
Clear cell carcinoma
Metastatic
None
0
1 or 2
Systemic Treatment-Naive
7 main criterias to confirm
Centre François Baclesse (Caen )
Gustave Roussy, Campus du cancer, Grand Paris
Phase 3
Lung cancer
#NCT05899608
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
Metastatic
Systemic Treatment-Naive
ALK
EGFR
ROS-1
8 main criterias to confirm
Centre François Baclesse (Caen ), CHU Caen Normandie (Caen)
Summit Therapeutics
Phase 3
Breast cancer
#NCT05232916
HER2 Positive
Localized
Locally Advanced
Other mutation
None
Targeted therapy
Targeted therapy
Systemic Treatment-Naive
Systemic Treatment-Naive
9 main criterias to confirm
Centre François Baclesse (Caen )
Greenwich LifeSciences, Inc.
Phase 3
Lung cancer
#NCT06430866
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Localized
Locally Advanced
Surgery
Chemotherapy
Surgery
Chemotherapy
ALK
EGFR
ROS-1
Immunotherapy
Immunotherapy
9 main criterias to confirm
Centre François Baclesse (Caen )
Amgen